Discordance in Management of Adverse Events Associated With Oral Therapies in Hormone Receptor–Positive Breast Cancer Among Healthcare Professionals and Experts: Findings From an Online Decision Support Tool

This poster, presented at ASCO Quality Care 2022, features an analysis of responses entered by healthcare professionals into an online treatment decision support tool for management of adverse events associated with CDK4/6, PI3K, and mTOR inhibitors in hormone receptor–positive breast cancer.


Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Cookie Settings